LPAR1 and ovarian carcinoma: Similarly, Yu et al. [24] reported significantly increased LPAR1 expression in patients with advanced clinical stages of epithelial ovarian cancer, an abdominal metastasis of more than 2 cm, retroperitoneal lymph node metastasis or hepatic metastasis.